Pharmally accuses Hontiveros of witness bribery; senator denies claim | Inquirer News

Pharmally accuses Hontiveros of witness bribery; senator denies claim

/ 03:34 PM September 29, 2021
Senator Risa Hontiveros warns of increasing Chinese incursion once 100% foreign ownership is allowed in the PH. Handout from Office of Sen. Risa Hontiveros

Senator Risa Hontiveros .Handout from Office of Sen. Risa Hontiveros

MANILA, Philippines —  Beleaguered trading company Pharmally Pharmaceutical Corp. is accusing Senator Risa Hontiveros of offering to bribe a witness who had testified before the Senate blue ribbon committee that the medical supplies procured by the government were substandard.

Pharmally, through its lawyer Ferdinand Topacio, presented on Wednesday video footage of another person who worked in the company’s warehouse claiming that a lawyer of Hontiveros offered the Senate’s witness money in exchange for fabricated testimony.


Last Friday, a witness who appeared before the committee, whose face was hidden, claimed that they were ordered by Pharmally officer Krizle Grace Mago to change the expiry dates on the face shields that would be supplied to the government.

Mago later admitted the allegations.


“[…] In a video that was presented by Atty. Topacio in a press conference a while ago,  another warehouse staff from Pharmally reveals that Sen. Hontiveros’ attorney offered his former co-worker money in exchange for testimony,” Pharmally said.

“In that said video, another Pharmally warehouseman identified his former co-worker as ‘V-Jay’, saying the latter was paid by (Hontiveros’ lawyer) through her driver,” it added.

The Pharmally warehouse staff claims the Senate’s witness was supposedly out to destroy the reputation of Pharmally and Mago, adding that no irregularity was done inside the warehouse.

This was even if Mago actually admitted that there was tampering of the expiration dates on the face shields.

“Nabayaran siya para siraan si Ms. Mago at Pharmally,” the other Pharmally warehouse staff explained.

“‘Dun po mismo ako nagtatrabaho sa warehouse at alam ko po ‘yung ginagawa namin ay tama at walang nangyayaring anomalya,” he added.

Hontiveros meanwhile denied the allegations saying they have “no track record” of “witness tampering [and] witness bribery.”


“First, it was the witness who reached out to us. We have an e-mail thread to prove this.  Like always, may resibo ako,” she said.  “We vetted the information of the witness for weeks and obtained independent corroboration of his points.”

“That is unrehearsed testimony. It is on the record. Kaya huwag na silang magtangkang ilihis pa ang usapan (So they should not attempt to divert the issue),” the senator said.

Mago’s revelation was made during the Senate committee hearing on the Commission on Audit (COA) report which showed P67.32 billion worth of deficiencies in the Department of Health (DOH) COVID-19 funds.

Part of that was the P42 billion funds transferred by the DOH to procuring agencies like the Procurement Service of the Department of Budget and Management, which awarded the P8.7 billion supplies contract to Pharmally despite the firm’s small paid-up capital of P625,000.

READ: P8.7-B med supply deals went to tiny company

The Senate offered to provide Mago with security after her testimony, but the Senate blue ribbon committee has not been able to locate her.  The panel has asked the National Bureau of Investigation to help locate Mago.

READ: Mago ‘incommunicado’ since damning testimony vs Pharmally

READ: Senate panel taps NBI to help locate Pharmally’s Mago

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Department of Health, expired face shields, face shields, Ferdinand Topacio, Pharmally Pharmaceutical Corp., Philippine news updates, Senate, Senate blue ribbon committee, Senator Risa Hontiveros
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.